HORIZON THERAPEUTICS PUB L's ticker is HZNP and the CUSIP is G46188101. A total of 494 filers reported holding HORIZON THERAPEUTICS PUB L in Q4 2020. The put-call ratio across all filers is 0.36 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $53,127,740 | +9.3% | 459,225 | -2.8% | 0.02% | +15.0% |
| Q2 2023 | $48,598,168 | -1.3% | 472,515 | +4.7% | 0.02% | -4.8% |
| Q1 2023 | $49,239,057 | -7.3% | 451,155 | -3.3% | 0.02% | -12.5% |
| Q4 2022 | $53,111,257 | -42.6% | 466,707 | -68.8% | 0.02% | -46.7% |
| Q3 2022 | $92,578,000 | +313.5% | 1,495,840 | +432.9% | 0.04% | +350.0% |
| Q2 2022 | $22,387,000 | +95.6% | 280,676 | +158.1% | 0.01% | +150.0% |
| Q1 2022 | $11,443,000 | -37.5% | 108,759 | -36.0% | 0.00% | -33.3% |
| Q4 2021 | $18,314,000 | +45.7% | 169,956 | +48.2% | 0.01% | +20.0% |
| Q3 2021 | $12,566,000 | -53.1% | 114,714 | -59.9% | 0.01% | -54.5% |
| Q2 2021 | $26,800,000 | +1.3% | 286,202 | -0.4% | 0.01% | -8.3% |
| Q1 2021 | $26,449,000 | +223.1% | 287,359 | +156.8% | 0.01% | +200.0% |
| Q4 2020 | $8,186,000 | -63.7% | 111,911 | -61.4% | 0.00% | -66.7% |
| Q3 2020 | $22,531,000 | +36.9% | 290,050 | -2.0% | 0.01% | +20.0% |
| Q2 2020 | $16,456,000 | +300.3% | 296,081 | +113.3% | 0.01% | +233.3% |
| Q1 2020 | $4,111,000 | -63.1% | 138,801 | -54.9% | 0.00% | -50.0% |
| Q4 2019 | $11,151,000 | +25.8% | 308,050 | -5.3% | 0.01% | 0.0% |
| Q3 2019 | $8,862,000 | +24.0% | 325,460 | +9.5% | 0.01% | +50.0% |
| Q2 2019 | $7,148,000 | – | 297,094 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kopp Family Office, LLC | 544,835 | $57,322,000 | 30.98% |
| Paulson & Co. | 5,614,000 | $590,649,000 | 18.18% |
| Avoro Capital Advisors LLC | 6,500,000 | $683,865,000 | 12.48% |
| 1492 Capital Management LLC | 121,840 | $12,819,000 | 6.80% |
| Iron Triangle Partners LP | 503,744 | $52,999,000 | 6.30% |
| Tri Locum Partners LP | 132,332 | $13,923,000 | 5.44% |
| HealthCor Management, L.P. | 710,110 | $74,711,000 | 4.98% |
| Eversept Partners, LP | 609,939 | $64,171,682 | 4.93% |
| Bain Capital Public Equity Management II, LLC | 1,286,371 | $135,339,000 | 4.33% |
| PFM Health Sciences, LP | 1,091,840 | $114,872,000 | 4.30% |